Cargando…
Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients
BACKGROUND: Humoral response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines needs to be evaluated in the fragile population of patients on maintenance haemodialysis (HD). METHODS: We analysed the antibody response to the spike (S) antigen of SARS-CoV-2 before and after...
Autores principales: | Giot, Matthieu, Fourié, Toscane, Lano, Guillaume, Villarroel, Paola Mariela Saba, de Lamballeri, Xavier, Gully, Marion, Samson, Laurent, Farault, Julien, Bouchouareb, Dammar, Jehel, Océane, Brunet, Philippe, Jourde-Chiche, Noémie, Ninove, Laetitia, Robert, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344612/ https://www.ncbi.nlm.nih.gov/pubmed/34603701 http://dx.doi.org/10.1093/ckj/sfab128 |
Ejemplares similares
-
Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19
por: Robert, Thomas, et al.
Publicado: (2022) -
Vaccination against COVID-19 in a haemodialysis centre: what is the risk of bleeding complications?
por: Giot, Matthieu, et al.
Publicado: (2021) -
Triage of Patients Suspected of COVID-19 in Chronic Hemodialysis: Eosinophil Count Differentiates Low and High Suspicion of COVID-19
por: Vial, Romain, et al.
Publicado: (2020) -
Étude SeroCOVIDial : évaluation de la séroprévalence SARS-CoV2 chez les patients hémodialysés chroniques et leurs soignants après la 1(re) vague et avant la campagne vaccinale, une étude de cohorte
por: Robert, T., et al.
Publicado: (2021) -
Determining the best window for BNT162b2 mRNA vaccination for
SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20
therapy
por: Rico, Audrey, et al.
Publicado: (2021)